Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1964 1
1966 2
1967 2
1968 3
1969 6
1970 6
1971 15
1972 14
1973 15
1974 17
1975 26
1976 23
1977 30
1978 31
1979 24
1980 37
1981 33
1982 49
1983 49
1984 35
1985 44
1986 52
1987 41
1988 44
1989 44
1990 63
1991 51
1992 54
1993 73
1994 53
1995 74
1996 67
1997 61
1998 83
1999 60
2000 70
2001 75
2002 63
2003 68
2004 76
2005 65
2006 76
2007 74
2008 88
2009 75
2010 77
2011 94
2012 87
2013 107
2014 77
2015 105
2016 95
2017 71
2018 69
2019 77
2020 57
2021 62
2022 62
2023 75
2024 102
2025 74
2026 48

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,165 results

Results by year

Filters applied: . Clear all
Page 1
Contraception Selection, Effectiveness, and Adverse Effects: A Review.
Teal S, Edelman A. Teal S, et al. JAMA. 2021 Dec 28;326(24):2507-2518. doi: 10.1001/jama.2021.21392. JAMA. 2021. PMID: 34962522 Review.
Pregnancy rates of women using oral contraceptives are 4% to 7% per year. Use of long-acting methods, such as intrauterine devices and subdermal implants, has increased substantially, from 6% of all contraceptive users in 2008 to 17.8% in 2016; these methods …
Pregnancy rates of women using oral contraceptives are 4% to 7% per year. Use of long-acting methods, such as intrauterine dev …
Evaluation of consumer self-selection of a proposed over-the-counter, progestin-only daily oral contraceptive.
Sober S, Bradford R, Henrie B, Pradeau S, Guillard H, Laurora I, Glasier A. Sober S, et al. Contraception. 2024 May;133:110401. doi: 10.1016/j.contraception.2024.110401. Epub 2024 Feb 29. Contraception. 2024. PMID: 38431260 Free article.
OBJECTIVES: In an effort to switch a norgestrel 0.075 mg progestin-only pill (Opill) from prescription to over-the-counter, we conducted this study to assess whether consumers can use the drug facts label alone to guide appropriate self-selection. STUDY DESIGN: Two studies …
OBJECTIVES: In an effort to switch a norgestrel 0.075 mg progestin-only pill (Opill) from prescription to over-the-counter, we conducted thi …
Premenstrual Dysphoric Disorder.
Lanza di Scalea T, Pearlstein T. Lanza di Scalea T, et al. Med Clin North Am. 2019 Jul;103(4):613-628. doi: 10.1016/j.mcna.2019.02.007. Med Clin North Am. 2019. PMID: 31078196 Review.
Serotonin reuptake inhibitors are considered the first-line treatment. Second-line treatments include oral contraceptives containing drospirenone, other ovulation suppression methods, calcium, chasteberry, and cognitive-behavioral therapy....
Serotonin reuptake inhibitors are considered the first-line treatment. Second-line treatments include oral contraceptives cont …
Premenstrual Dysphoric Disorder.
Lanza di Scalea T, Pearlstein T. Lanza di Scalea T, et al. Psychiatr Clin North Am. 2017 Jun;40(2):201-216. doi: 10.1016/j.psc.2017.01.002. Epub 2017 Mar 1. Psychiatr Clin North Am. 2017. PMID: 28477648 Review.
Serotonin reuptake inhibitors are considered the first-line treatment. Second-line treatments include oral contraceptives containing drospirenone, other ovulation suppression methods, calcium, chasteberry, and cognitive-behavioral therapy....
Serotonin reuptake inhibitors are considered the first-line treatment. Second-line treatments include oral contraceptives cont …
Newer progestogens.
Rowlands S. Rowlands S. J Fam Plann Reprod Health Care. 2003 Jan;29(1):13-6. doi: 10.1783/147118903101197188. J Fam Plann Reprod Health Care. 2003. PMID: 12626173 Free article. Review.
DATA SOURCES: Searches of Medline and Popline together with requests for bibliographies from the Population Council, Wyeth-Ayerst Research and Schering Health Care. STUDY SELECTION: Information from technical papers was used to ascertain the metabolic characteristics and r …
DATA SOURCES: Searches of Medline and Popline together with requests for bibliographies from the Population Council, Wyeth-Ayerst Research a …
Combined oral contraceptive with estetrol plus drospirenone: from pharmacokinetics to clinical applications.
Battipaglia C, Feliciello L, Genazzani AD, Facchinetti F, Grandi G. Battipaglia C, et al. Expert Opin Drug Metab Toxicol. 2023 Dec;19(12):871-879. doi: 10.1080/17425255.2023.2279752. Epub 2024 Jan 12. Expert Opin Drug Metab Toxicol. 2023. PMID: 37942662 Review.
INTRODUCTION: Drospirenone/estetrol (DRSP/E4) is a combined oral contraceptive (COC) recently approved in several countries. It is composed of 15 mg of E4, a natural estrogen produced by human fetal liver throughout pregnancy, and 3 mg of DRSP, the first synthetic p …
INTRODUCTION: Drospirenone/estetrol (DRSP/E4) is a combined oral contraceptive (COC) recently approved in several countries. I …
Oral contraceptive use.
Wilkins K, Johansen H, Beaudet MP, Neutel CI. Wilkins K, et al. Health Rep. 2000 Spring;11(4):25-37 (Eng); 27-41 (Fre). Health Rep. 2000. PMID: 10879328 English, French.
OBJECTIVES: This article profiles Canadian women aged 15 to 49 who use oral contraceptives (OCs), and compares certain of their characteristics with those of non-users. ...ANALYTICAL TECHNIQUES: Cross-tabulations were used to estimate the percentage of women aged 15 …
OBJECTIVES: This article profiles Canadian women aged 15 to 49 who use oral contraceptives (OCs), and compares certain of thei …
Norgestimate.
Corson SL. Corson SL. Clin Obstet Gynecol. 1995 Dec;38(4):841-8. doi: 10.1097/00003081-199538040-00019. Clin Obstet Gynecol. 1995. PMID: 8616980 Review.
Norgestimate (NGM) is one of a class of newer, more selective progestins. The authors describe its structure and biologic activity, contraceptive effectiveness, cycle control, metabolic effects, carbohydrate metabolism, coagulation factors, and clinical side effects …
Norgestimate (NGM) is one of a class of newer, more selective progestins. The authors describe its structure and biologic activity, …
Estradiol valerate/dienogest: a novel oral contraceptive.
Whalen KL, Rose R. Whalen KL, et al. Ann Pharmacother. 2011 Oct;45(10):1256-61. doi: 10.1345/aph.1Q216. Epub 2011 Sep 13. Ann Pharmacother. 2011. PMID: 21917554 Review.
Menstrual bleeding patterns and cycle control with estradiol valerate/dienogest were comparable to those of a monophasic oral contraceptive containing ethinyl estradiol/levonorgestrel. Estradiol valerate/dienogest differs from other oral contraceptives …
Menstrual bleeding patterns and cycle control with estradiol valerate/dienogest were comparable to those of a monophasic oral cont …
Contraception and dyslipidemia.
Knopp RH, LaRosa JC, Burkman RT Jr. Knopp RH, et al. Am J Obstet Gynecol. 1993 Jun;168(6 Pt 2):1994-2005. doi: 10.1016/s0002-9378(12)90941-2. Am J Obstet Gynecol. 1993. PMID: 8512044 Review.
Major coronary events are rare among reproductive-age women who use oral contraceptives and are related to the concomitant effects of age, smoking, diabetes, hypertension, and obesity. Low estrogen-progestin dose oral contraceptives appear not to promo …
Major coronary events are rare among reproductive-age women who use oral contraceptives and are related to the concomitant eff …
3,165 results